National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial


Phase 2 Results N/A

Summary of Purpose

The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 January 2016.

1 May 2003 23 Jun 2003 1 May 2005 1 Jul 2005 1 Jan 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment


Not available